Drug Resistance in Melanoma: New Perspectives
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
387-391
Author(s):
Caterina A.M. La Porta
Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
31-40
Author(s):
Alexander J. Muller and George C. Prendergast
Subject Index To Volume 6
Journal:
Current Molecular Medicine
Volume:
7
Page:
v-xv
Author(s):
New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
73-78
Author(s):
Floriana Facchetti, Elena Monzani and Caterina A.M. La Porta
Role of Alterations in the Apoptotic Machinery in Sensitivity of Cancer Cells to Treatment
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
4411-4425
Author(s):
Salvador Rodriguez-Nieto and Boris Zhivotovsky
The Redox Regulation of Thiol Dependent Signaling Pathways in Cancer
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
4427-4443
Author(s):
Gregory I. Giles
New Generation of Liposomal Drugs for Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
537-552
Author(s):
Tamara Minko, Refika I. Pakunlu, Yang Wang, Jayant J. Khandare and Maha Saad
TGF Beta Inhibition for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
565-578
Author(s):
Elise F. Saunier and Rosemary J. Akhurst
Adrenomedullin: A Tumor Progression Factor via Angiogenic Control
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
635-643
Author(s):
Misa Nakamura, Bo Han, Osamu Nunobiki and Kennichi Kakudo
Clinical Features of Scleroderma-Like Disorders: A Challenge for the Rheumatologist
Journal:
Current Rheumatology Reviews
Volume:
2
Page:
369-379
Author(s):
Laszlo Czirjak and Cecilia Varju